Pieris Pharmaceuticals, Inc. (PIRS)
NASDAQ: PIRS · Real-Time Price · USD
16.01
+0.54 (3.49%)
Nov 20, 2024, 4:00 PM EST - Market open
Pieris Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 21 | 18 | 77 | 272 | 140 | 199 | |
| Market Cap Growth | -25.69% | -76.75% | -71.59% | 94.67% | -29.69% | 38.17% | |
| Enterprise Value | 2 | -15 | 20 | 163 | 74 | 113 | |
| Last Close Price | 16.01 | 14.56 | 83.20 | 302.40 | 200.00 | 289.60 | |
| PS Ratio | 15.07 | 0.42 | 2.99 | 8.67 | 4.77 | 4.30 | |
| PB Ratio | 1.30 | 0.67 | 2.77 | 5.37 | 4.51 | 3.88 | |
| P/TBV Ratio | 1.35 | 0.67 | 2.77 | 5.37 | 4.51 | 3.88 | |
| EV/Sales Ratio | 1.36 | - | 0.76 | 5.18 | 2.51 | 2.44 | |
| Debt / Equity Ratio | - | - | 0.47 | 0.29 | 0.55 | 0.32 | |
| Asset Turnover | 0.03 | 0.64 | 0.21 | 0.24 | 0.24 | 0.33 | |
| Quick Ratio | 4.76 | 2.72 | 1.92 | 2.39 | 3.26 | 4.11 | |
| Current Ratio | 4.82 | 3.24 | 2.01 | 2.52 | 3.42 | 4.26 | |
| Return on Equity (ROE) | -68.21% | -89.76% | -84.58% | -111.85% | -90.39% | -55.80% | |
| Return on Assets (ROA) | -28.31% | -14.76% | -21.82% | -25.06% | -17.23% | -12.02% | |
| Return on Capital (ROIC) | -38.30% | -29.22% | -50.94% | -57.02% | -36.69% | -31.58% | |
| Earnings Yield | -75.25% | -136.42% | -43.00% | -16.79% | -26.61% | -12.80% | |
| FCF Yield | -132.00% | -300.09% | -78.79% | -3.16% | -34.75% | -27.60% | |
| Buyback Yield / Dilution | -21.29% | -21.43% | -14.91% | -18.48% | -7.62% | 4.63% | |
| Total Shareholder Return | -21.29% | -21.43% | -14.91% | -18.48% | -7.62% | 4.63% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.